Homeostatic T helper 17 cell responses triggered by complex microbiota are maintained in ex vivo intestinal tissue slices.

Autor: Beneke V; Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) Research Network, Hannover, Germany.; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany., Grieger KM; Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) Research Network, Hannover, Germany.; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany., Hartwig C; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.; Department of In-vitro Diagnostics, Fraunhofer Institute for Interfacial Engineering and Biotechnology, Stuttgart, Germany., Müller J; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.; Department of In-vitro Diagnostics, Fraunhofer Institute for Interfacial Engineering and Biotechnology, Stuttgart, Germany.; Center of Integrative Bioinformatics Vienna (CIBIV), Max Perutz Labs, University of Vienna and Medical University of Vienna, Vienna BioCenter, Vienna, Austria.; Member of the Vienna Biocenter PhD Program, University of Vienna and the Medical University of Vienna, Vienna, Austria., Sohn K; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.; Department of In-vitro Diagnostics, Fraunhofer Institute for Interfacial Engineering and Biotechnology, Stuttgart, Germany., Blaudszun AR; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.; Department of Cell and Gene Therapy Development, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany., Hilger N; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.; Department of Cell and Gene Therapy Development, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany., Schaudien D; Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany., Fricke S; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.; Department of Cell and Gene Therapy Development, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany., Braun A; Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) Research Network, Hannover, Germany.; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.; Institute for Immunology, Hannover Medical School, Hannover, Germany., Sewald K; Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) Research Network, Hannover, Germany.; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany., Hesse C; Division of Preclinical Pharmacology and Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH) Research Network, Hannover, Germany.; Member of the Fraunhofer Excellence Cluster of Immune Mediated Diseases (CIMD), Germany.

Publikováno v: European journal of immunology [Eur J Immunol] 2024 Aug; Vol. 54 (8), pp. e2350946. Date of Electronic Publication: 2024 May 19.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Eukaryotic and prokaryotic contributions to colonic hydrogen sulfide synthesis.

Autor: Flannigan, K L., McCoy, K. D., Wallace, J. L.

Publikováno v: American Journal of Physiology: Gastrointestinal & Liver Physiology; Jul2011, Vol. 301, pG188-G193, 6p

GYY4137, as a slow-releasing H2S donor, ameliorates sodium deoxycholate–induced chronic intestinal barrier injury and gut microbiota dysbiosis.

Autor: Pan, Shaorong, Yan, Han, Zhu, Jing, Ma, Yuanyuan, Wang, Pengyuan, Liu, Yucun, Chen, Zeyang

Publikováno v: Frontiers in Pharmacology; 2024, p1-15, 15p

Regulation of Cholecystokinin-Mediated Amylase Secretion by Leptin in Rat Pancreatic Acinar Tumor Cell Line AR42J.

Autor: Harris, D. M., Flannigan, K. L., Go, V. L. W., Wu, S. V.

Publikováno v: Pancreas; Oct1999, Vol. 19 Issue 3, p224-230, 7p